Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
David Baker(Quadram Institute), Klaus Schmierer(Queen Mary University of London)
Cited by 288
Related Papers
Pharmaco-metabonomic phenotyping and personalized drug treatment
|Nature|2006|827
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
|Proceedings of the National Academy of Sciences|2009|764
The therapeutic potential of cannabis
|The Lancet Neurology|2003|346
Association between pathological and MRI findings in multiple sclerosis
|The Lancet Neurology|2019|251